Poster discussion lipid mediators--new agents
DeVries, G.W.; Jacobs, R.S.
Agents and Actions. Supplements 47: 203-205
1995
ISSN/ISBN: 0379-0363 PMID: 7785500 Document Number: 440551
Document emailed within 1 workday
Related Documents
Coulston, A.M.; Stivers, M. 1993: A poster worth a thousand words. How to design effective poster session displays Journal of the American Dietetic Association 93(8): 865-866Northwood, J.Blackman. 2008: Clinical Microbiology and Infectious Diseases (ECCMID)--18th European Congress. New antimicrobial agents: selected poster presentations IDrugs: the investigational drugs journal 11(6): 405-408
Lefer, A.M. 1989: Significance of lipid mediators in shock states Circulatory Shock 27(1): 3-12
Goetzl, E.J. 1987: Leukocyte receptors for lipid and peptide mediators Federation Proceedings 46(1): 190-191
Pretolani, M.; Vargaftig, B.B. 1991: Role of lipid mediators in allergic reactions Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 185(1-2): 37-45
Windler, E. 1987: Lipoprotein receptors of the liver. Pivotal mediators of lipid metabolism Fortschritte der Medizin 105(36): 716-718
Endo, J.; Arita, M. 2011: Roles of lipid mediators in controlling vascular inflammation and the progression of atherosclerosis Nihon Rinsho. Japanese Journal of Clinical Medicine 69(1): 34-38
Levy, B.D.; Serhan, C.N. 2003: Exploring new approaches to the treatment of asthma: potential roles for lipoxins and aspirin-triggered lipid mediators Drugs of Today 39(5): 373-384
Puget, J 2017: Discussion of Dominique Scarfones Paper, On That Is Not Psychoanalysis: Ethics as the Main Tool for Psychoanalytic Knowledge and Discussion: Terminable and Interminable Discussion Psychoanalytic Dialogues 27(4): 401-405
Puget, J 2017: Discussion of Dominique Scarfones Paper, On That Is Not Psychoanalysis: Ethics as the Main Tool for Psychoanalytic Knowledge and Discussion: Terminable and Interminable Discussion Psychoanalytic Dialogues 27(4): 401-405
Puget, J 2017: Discussion of Dominique Scarfones Paper, On That Is Not Psychoanalysis: Ethics as the Main Tool for Psychoanalytic Knowledge and Discussion: Terminable and Interminable Discussion Psychoanalytic Dialogues 27(4): 401-405
Horsmans, Y.; Larrey, D.; Pessayre, D.; Benhamou, J.P. 1990: Hepatotoxicity of antimicrobial agents. II: Urinary antiseptics, antitubercular agents, antiparasitic agents, antifungal agents, antiviral agents Gastroenterologie Clinique et Biologique 14(12): 919-924
1997: What is new? Therapy with lipid lowering agents Der Internist 38(11 Suppl Therapie): 1-8
Wang, G.J.; Chung, K.C.; Shen, W.J. 1995: Lipid clearing agents in steroid-induced osteoporosis Journal of the Formosan Medical Association 94(10): 589-592
Amarenco, P. 2001: Hypercholesterolemia, lipid-lowering agents, and the risk for brain infarction Neurology 57(5 Suppl 2): S35-S44
Kokot, F.; Szczechowska, E. 1981: Comparison of the lipid-lowering agents clofibrate and bezafibrate in patients with hyperlipoproteinemias IIa and IIb Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 36(13): 454-457
Mago, N.; Khuller, G.K. 1989: Influence of lipid composition on the sensitivity of Candida albicans to antifungal agents Indian Journal of Biochemistry and Biophysics 26(1): 30-33
Kuemmerle, H.P. 1981: Lipid-lowering agents and their meaning in the treatment of the fat metabolism-atherosclerosis functional circle International Journal of Clinical Pharmacology Therapy and Toxicology 19(7): 289-296
Fujita, H.; Matsuo, I. 1994: In vitro phototoxic activities of new quinolone antibacterial agents: lipid peroxidative potentials Photodermatology Photoimmunology and Photomedicine 10(5): 202-205
Okabe, K.; Fujisawa, K.; Takahashi, T. 1970: Therapeutic agents for lipid metabolism disorders--with special reference to fatty liver Nihon Rinsho. Japanese Journal of Clinical Medicine 28: Suppl: 700-3